Contact Us for a Free Consultation 914-371-3600

Blog

FDA’s Lax Methodology, Part 2

Posted by Andrew J. Barovick | Jan 11, 2009 | 0 Comments

In my December 10 posting, I discussed how physicians are troubled by the FDA's lax methodology in conducting clinical trial of drugs and medical devices. In today's Torts Prof Blog , Bill Childs points out that today's NY Times features an article by Gardiner Harris  entitled, “ F.D.A. Is Lax On Oversight During Trials, Inquiry Finds.”

The focus of today's news is the FDA's historic failure to address the financial conflicts  of doctors conducting clinical trials of drugs and medical devices.  Apparently, there are growing concerns that money accepted by doctors from drug and device makers “may hurt patients and skew studies,” according to Mr. Gardiner. 

You may remember that in my January 9 posting, I noted that the New England Journal of Medicine had instituted a new policy to disclose financial conflicts of its physician-authors, news to which I was alerted by Gardiner Harris's article in that day's NY Times. 

I am hopeful that our President-Elect's appointment of a new Surgeon General will help get the FDA back on track.  It would be nice to see that organization receive some press that did not reveal the existence of sloppy and potentially dangerous procedures.

In the meanwhile, it is outrageous that federal preemption remains available to protect drug and device companies whose products have been cleared by the FDA from lawsuits by victims of negligence in state courts.   When the FDA's own clinical trials are suspect, the products that have passed clinical trials are suspect.  So it should not come as a shock that they might injure or kill an end user.  It is simply not fair to prevent a medical consumer who relied on the FDA's “stamp of approval” from seeking redress in state court.  Stay tuned.

About the Author

Andrew J. Barovick

Mr. Barovick is a graduate of Columbia College and Cardozo School of Law. He began his legal career at the Queens District Attorney’s Office, where he tried over 20 felonies to verdict, and argued an equal number of appeals before the Appellate Division, Second Department, the New York Court of Appeals and the United States Court of Appeals for the Second Circuit.

Comments

There are no comments for this post. Be the first and Add your Comment below.

Leave a Comment

REPRESENTATIVE VERDICTS & SETTLEMENTS:

$7.9 million dollars for infant client who suffered severe brain injuries due to post- delivery medical malpractice.

$500,000 wrongful death/medical malpractice settlement on behalf of patient brought to hospital emergency room with serious injuries who suffered complications while unmonitored and died.

$425,000 wrongful death/medical malpractice settlement during trial on behalf of senior hospital patient whose surgeon failed to timely address her worsening symptoms, resulting in her death.

$250,000 to young man whose physician failed to diagnose an impending torsion testicle, causing the loss of the affected testicle.

$200,000 to young mother whose OB/GYN failed to timely diagnose and treat her ectopic pregnancy, resulting in excruciating, long-term pain and the need for surgery to address the ectopic pregnancy once it was diagnosed.

Menu